Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000804642 | SCV000944559 | uncertain significance | Brugada syndrome | 2018-12-10 | criteria provided, single submitter | clinical testing | This sequence change replaces methionine with threonine at codon 1435 of the SCN10A protein (p.Met1435Thr). The methionine residue is highly conserved and there is a moderate physicochemical difference between methionine and threonine. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has not been reported in the literature in individuals with SCN10A-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004028184 | SCV003997326 | uncertain significance | Cardiovascular phenotype | 2023-04-04 | criteria provided, single submitter | clinical testing | The c.4304T>C (p.M1435T) alteration is located in exon 25 (coding exon 25) of the SCN10A gene. This alteration results from a T to C substitution at nucleotide position 4304, causing the methionine (M) at amino acid position 1435 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |